Yuzefpolskiy Y, Morawski P, Fahning M, Speake C, et al. Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients. J Immunol 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
PMID: 35288472